GB1266889A - - Google Patents

Info

Publication number
GB1266889A
GB1266889A GB1266889DA GB1266889A GB 1266889 A GB1266889 A GB 1266889A GB 1266889D A GB1266889D A GB 1266889DA GB 1266889 A GB1266889 A GB 1266889A
Authority
GB
United Kingdom
Prior art keywords
dihydro
hydroxy
ethano
ethanoanthracene
anthryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH728468A external-priority patent/CH507897A/de
Priority claimed from CH448069A external-priority patent/CH539602A/de
Application filed filed Critical
Publication of GB1266889A publication Critical patent/GB1266889A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB1266889D 1968-05-16 1969-04-30 Expired GB1266889A (US07179912-20070220-C00144.png)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH728468A CH507897A (de) 1968-05-16 1968-05-16 Verfahren zur Herstellung von N-substituierten 9-(Aminoalkyl)-9,10-dihydro-9,10-äthano-anthrazenen
CH448069A CH539602A (de) 1969-03-25 1969-03-25 Verfahren zur Herstellung von neuen N-substituierten 9-(Aminoalkyl)-9,10-dihydro-9,10-äthano-anthrazenen

Publications (1)

Publication Number Publication Date
GB1266889A true GB1266889A (US07179912-20070220-C00144.png) 1972-03-15

Family

ID=25695575

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1266889D Expired GB1266889A (US07179912-20070220-C00144.png) 1968-05-16 1969-04-30

Country Status (13)

Country Link
US (2) US3778467A (US07179912-20070220-C00144.png)
JP (3) JPS4931982B1 (US07179912-20070220-C00144.png)
AT (6) AT304488B (US07179912-20070220-C00144.png)
BE (1) BE733092A (US07179912-20070220-C00144.png)
CA (1) CA927383A (US07179912-20070220-C00144.png)
DE (1) DE1923195A1 (US07179912-20070220-C00144.png)
ES (5) ES367292A1 (US07179912-20070220-C00144.png)
FR (1) FR2009896A1 (US07179912-20070220-C00144.png)
GB (1) GB1266889A (US07179912-20070220-C00144.png)
HU (1) HU162752B (US07179912-20070220-C00144.png)
NL (1) NL6907455A (US07179912-20070220-C00144.png)
SE (1) SE360852B (US07179912-20070220-C00144.png)
SU (3) SU404227A3 (US07179912-20070220-C00144.png)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS527972A (en) * 1975-07-07 1977-01-21 Sumitomo Chem Co Ltd Process for preparing novel morpholine derivatives
US5512575A (en) * 1991-08-15 1996-04-30 Zeneca Limited Methanoanthraceneyl methyl piperidinyl compounds
GB9216298D0 (en) * 1991-08-15 1992-09-16 Ici Plc Piperidine derivatives
GB9216297D0 (en) * 1991-08-15 1992-09-16 Ici Plc Therapeutic agents

Also Published As

Publication number Publication date
ES388316A1 (es) 1973-12-16
DE1923195A1 (de) 1969-11-27
NL6907455A (US07179912-20070220-C00144.png) 1969-11-18
AT304487B (de) 1973-01-10
JPS4931982B1 (US07179912-20070220-C00144.png) 1974-08-27
AT304489B (de) 1973-01-10
ES388315A1 (es) 1973-12-16
BE733092A (US07179912-20070220-C00144.png) 1969-11-14
SU414786A3 (US07179912-20070220-C00144.png) 1974-02-05
US3778467A (en) 1973-12-11
AT304486B (de) 1973-01-10
AT304507B (de) 1973-01-10
SU407442A3 (US07179912-20070220-C00144.png) 1973-11-21
FR2009896B1 (US07179912-20070220-C00144.png) 1974-04-12
CA927383A (en) 1973-05-29
US3821214A (en) 1974-06-28
JPS4921132B1 (US07179912-20070220-C00144.png) 1974-05-30
HU162752B (US07179912-20070220-C00144.png) 1973-04-28
ES367292A1 (es) 1971-05-01
SE360852B (US07179912-20070220-C00144.png) 1973-10-08
AT303019B (de) 1972-10-15
SU404227A3 (US07179912-20070220-C00144.png) 1973-10-26
ES388313A1 (es) 1973-12-16
AT304488B (de) 1973-01-10
ES388317A1 (es) 1973-12-16
FR2009896A1 (fr) 1970-02-13
JPS4813543B1 (US07179912-20070220-C00144.png) 1973-04-27

Similar Documents

Publication Publication Date Title
GB1351263A (en) Eburnane derivatives
GB1503581A (en) Process for the manufacture of 7-beta-amino-cephem-3-ol-4-carboxylic acid compounds
GB1301973A (US07179912-20070220-C00144.png)
GB1373212A (en) Pyrazole compounds
GB1266889A (US07179912-20070220-C00144.png)
GB1268951A (en) Phenoxy-amines
GB1352245A (en) Azabicyclo-3.3.1-nonan-3-ol ester derivatives
GB1283632A (en) Phenylethanolamine derivatives
GB1141214A (en) New derivatives of proscillaridin a
GB1513724A (en) Derivatives of thiocolchicine
GB1266890A (US07179912-20070220-C00144.png)
GB1219387A (en) Bicyclo[2.2.2]oct-2-ene-amino acid compounds
GB1269832A (en) TRICYCLO(4.4.0.0<3.8>)DECAN-1-AMINE AND alpha-METHYLTRICYCLO(4.4.0.0<3.8>)DECAN-1-METHYLAMINE AND PROCESS FOR PREPARING SAME
GB1282822A (en) Butanolamine derivatives
GB1451389A (en) Indolobenzazepines
GB1468333A (en) Ketoglutaric acid derivatives
ES445343A1 (es) Procedimiento para la preparacion de derivados cuaternarios de xantinil-alcohil-nortropina.
GB1378964A (en) Pyridine derivatives
GB1284423A (en) Cyclohexa-1,4-diene-1-acetic acids
GB1328169A (en) Benzamide compounds and methods for their production
GB1137654A (en) 5-halosalicylic acid derivatives
GB1298057A (en) Bis(aminoalkylsulphamoyl)anthraquinones
GB1417817A (en) Substituted acetic acid cyclohexyl esters the preparation thereof and pharmaceutical compositions containing them
GB1189217A (en) 09-nor-Testosterone Phenoxyacetate and 6-Methyl Derivatives thereof
GB1368251A (en) Theophylinylmethylethanoic acid ester

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PLNP Patent lapsed through nonpayment of renewal fees